Video

Patient Treatment Changes Over the Past Few Years

Author(s):

Ana M. Molina, MD

Ana M. Molina, M.D. Genitourinary Oncology Service from Memorial Sloan-Kettering Cancer Center in New York Talks About how Patient Treatment has Changed Over the Past Few Years

Ana M. Molina, M.D. Genitourinary Oncology Service from Memorial Sloan-Kettering Cancer Center in New York Talks About how Patient Treatment has Changed Over the Past Few Years

Related Videos
Yungan Tao, MD
Jared Weiss, MD
Guru P. Sonpavde, MD
Martin H. Voss, MD
Sally Lau, MD
Hope S. Rugo, MD
Amrita Krishnan, MD, executive medical director, Hematology, director, Judy and Bernard Briskin Multiple Myeloma Center, professor, Department of Hematology & Hematopoietic Cell Transplantation, City of Hope
Idoroenyi Amanam, MD
Francisco Hernandez-Ilizaliturri, MD, professor, oncology, Department of Medicine—Lymphoma; director, Lymphoma Research, head, Lymphoma Translational Research Lab; associate professor, Department of Immunology, Roswell Park Comprehensive Cancer Center; clinical professor, Department of Medicine, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo
Srikala Sridhar, MD, MSc, FRCPC
Related Content
Updates and Advances in Early Stage Breast Cancer
April 5th 2023

Updates and Advances in Early Stage Breast Cancer

Manali Kamdar, MD
December 11th 2021

Dr. Kamdar on the Results of the TRANSFORM Trial in Relapsed/Refractory LBCL

Brandon Blue, MD
October 1st 2021

Dr. Blue on the Utility of Carfilzomib in Relapsed/Refractory Multiple Myeloma

Randall Shares How Postoperative Radiotherapy Retains a Role in Soft Tissue Sarcoma
July 29th 2020

Randall Shares How Postoperative Radiotherapy Retains a Role in Soft Tissue Sarcoma

Dr. Jacobson on the Benefit of Axi-Cel in Relapsed/Refractory Follicular Lymphoma
June 11th 2020

Dr. Jacobson on the Benefit of Axi-Cel in Relapsed/Refractory Follicular Lymphoma

Dr. Katz on Determining Low-Risk Disease in Prostate Cancer
June 2nd 2020

Dr. Katz on Determining Low-Risk Disease in Prostate Cancer